Recent Finacing
Recent Raise
Solid GT, a subsidiary of Solid Biosciences, develops a gene therapy platform for Duchenne muscular dystrophy; candidates show efficacy in animal models and are in IND‑enabling studies with clinical partners.
Recent Investors
Total Raised
Funding round
Investors
